TECNIS 3-Piece Acrylic Monofocal, Model ZA9003
Johnson & Johnson Surgical Vision, Inc. · Decision date Jul 22, 2025
What did the FDA decide?
FDA records P990080/S063 as a supplement to PMA P990080, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 22, 2025.
FDA approval order statement
error proofing and yield improvement updates to Measuring intraocular lens (IOL) Quality (MIQ) system software
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Jul 22, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P990080/S063
- Regulatory pathway
- PMA supplement
- Product code
- HQL
- Decision code
- OK30
- Decision date
- Jul 22, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Product code
- HQL
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P990080. Subsequent supplements may change the device or its indications.
FDA decision timeline
P990080 · Original PMA
CEEON EDGE FOLDABLE ULTRAVIOLET LIGHT-ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS, MODEL 911A
P990080/S063 received
Application receipt date recorded by FDA.
P990080/S063 · FDA decision
30-Day Notice
P990080/S064 · Related supplement
TECNIS 3-Piece Acrylic Monofocal, Model ZA9003
P990080/S062 · Related supplement
TECNIS Foldable Acrylic IOL with OptiEdge
P990080/S065 · Related supplement
TECNIS Foldable Acrylic IOL with OptiEdge, 13.0 mm, ZA9003
P990080/S066 · Related supplement
TECNIS 3-Piece Acrylic Monofocal, Model ZA9003
P990080/S067 · Related supplement
TECNIS Foldable Acrylic IOL with OptiEdge, Model ZA9003
Timeline entries are records held by MedtechLedger for P990080. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P990080
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | PMA approval | Apr 5, 2001 | FDA | |
TECNIS 3-Piece Acrylic Monofocal, Model ZA9003P990080/S064 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Sep 2, 2025 | FDA |
TECNIS Foldable Acrylic IOL with OptiEdgeP990080/S062 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Sep 10, 2025 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Jan 12, 2026 | FDA | |
TECNIS 3-Piece Acrylic Monofocal, Model ZA9003P990080/S066 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Jun 3, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038/S004 | Beaver-Visitec International, Inc. | PMA supplement | Oct 27, 2026 | FDA |
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
enVista Hydrophobic Acrylic Intraocular LensP910056/S066 | Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Johnson & Johnson Surgical Vision, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 31 Technology Dr., Suite 200, Irvine, CA, 92618
Sources and methodology
- Original FDA record: P990080/S063
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





